Fat poetry:: a kingdom for PPARγ

被引：116

作者：

Anghel, Silvia I. ^{[1
]}

Wahli, Walter ^{[1
]}

机构：

[1] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland

来源：

CELL RESEARCH | 2007年 / 17卷 / 06期

关键词：

adipose tissue; energy homeostasis; obesity; peroxisome proliferator-activated receptor;

D O I：

10.1038/cr.2007.48

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Adipose tissue is not an inert cell mass contributing only to the storage of fat, but a sophisticated ensemble of cellular components with highly specialized and complex functions. In addition to managing the most important energy reserve of the body, it secretes a multitude of soluble proteins called adipokines, which have beneficial or, alternatively, deleterious effects on the homeostasis of the whole body. The expression of these adipokines is an integrated response to various signals received from many organs, which depends heavily on the integrity and physiological status of the adipose tissue. One of the main regulators of gene expression in fat is the transcription factor peroxisome proliferator-activated receptor gamma (PPAR gamma), which is a fatty acid- and eicosanoid-dependent nuclear receptor that plays key roles in the development and maintenance of the adipose tissue. Furthermore, synthetic PPAR gamma agonists are therapeutic agents used in the treatment of type 2 diabetes. This review discusses recent knowledge on the link between fat physiology and metabolic diseases, and the roles of PPAR gamma in this interplay via the regulation of lipid and glucose metabolism. Finally, we assess the putative benefits of targeting this nuclear receptor with still-to-be-identified highly selective PPAR gamma modulators.

引用

页码：486 / 511

页数：26

共 255 条

[1] Benzoyl 2-methyl indoles as selective PPARγ modulators [J].

Acton, JJ ;

Black, RM ;

Jones, AB ;

Moller, DE ;

Colwell, L ;

Doebber, TW ;

MacNaul, KL ;

Berger, J ;

Wood, HB .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) :357-362

[2] A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy [J].

Agarwal, AK ;

Garg, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :408-411

[3] Tyrosine Agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor γ [J].

Agostini, M ;

Gurnell, M ;

Savage, DB ;

Wood, EM ;

Smith, AG ;

Rajanayagam, O ;

Garnes, KT ;

Levinson, SH ;

Xu, HE ;

Schwabe, JWR ;

Willson, TM ;

O'Rahilly, S ;

Chatterjee, VK .

ENDOCRINOLOGY, 2004, 145 (04) :1527-1538

[4] Brain adipocytokine action and metabolic regulation [J].

Ahima, Rexford S. ;

Qi, Yong ;

Singhal, Neel S. ;

Jackson, Malaka B. ;

Scherer, Philipp E. .

DIABETES, 2006, 55 :S145-S154

[5] Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome [J].

Ailhaud, Gerard .

COMPTES RENDUS BIOLOGIES, 2006, 329 (08) :570-577

[6] Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats [J].

Akiray, EM ;

Chan, O ;

Inouye, K ;

Riddell, MC ;

Matthews, SG ;

Vranic, M .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (12) :1558-1564

[7] PAI-1 and the metabolic syndrome - Links, causes, and consequences [J].

Alessi, Marie-Christine ;

Juhan-Vague, Irene .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) :2200-2207

[8] Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity [J].

Alessi, MC ;

Bastelica, D ;

Morange, P ;

Berthet, B ;

Leduc, I ;

Verdier, M ;

Geel, O ;

Juhan-Vague, I .

DIABETES, 2000, 49 (08) :1374-1380

[9] Halofenate is a selective peroxisome proliferator-activated receptor γ modulator with antidiabetic activity [J].

Allen, Tamara ;

Zhang, Fang ;

Moodie, Shonna A. ;

Clemens, L. Edward ;

Smith, Aaron ;

Gregoire, Francine ;

Bell, Andrea ;

Muscat, George E. O. ;

Gustafson, Thomas A. .

DIABETES, 2006, 55 (09) :2523-2533

[10] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].

Altshuler, D ;

Hirschhorn, JN ;

Klannemark, M ;

Lindgren, CM ;

Vohl, MC ;

Nemesh, J ;

Lane, CR ;

Schaffner, SF ;

Bolk, S ;

Brewer, C ;

Tuomi, T ;

Gaudet, D ;

Hudson, TJ ;

Daly, M ;

Groop, L ;

Lander, ES .

NATURE GENETICS, 2000, 26 (01) :76-80

← 1 2 3 4 5 6 7 8 9 10 →